Christel Larbouret, Nadège Gaborit, Thierry Chardès, Mickaël Coelho, Emmanuelle Campigna, et al.. In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption..
Neoplasia : An International Journal for Oncology Research, Elsevier, 2012, 14 (2), pp.121-30.
⟨10.1593/neo.111602⟩.
⟨inserm-00682017⟩